Related Experiment Video
Updated: Aug 31, 2026

Development and Characterization of Fusidic Acid-Loaded Alginate-Aloe vera Based Hydrogel Film
Published on: December 13, 2024
Fusidic acid-induced leukopenia and thrombocytopenia
Yu-Min Liao1, Chang-Fang Chiu, Mao-Wang Ho
1Division of Hematology/Oncology, Department of Internal Medicine, China Medical College Hospital, Taichung, Taiwan, ROC.
Abstract:
Fusidic acid is an active agent against a wide variety of gram-positive bacteria, and it has been increasingly used in methicillin-resistant Staphylococcus aureus infection. The major adverse effects are mild gastrointestinal discomfort and diarrhea. The hematological side effects such as granulocytopenia and thrombocytopenia have been rarely reported in western countries, but have not been documented in Asian population. Between January and April 2001, we identified 2 cases of fusidic acid-induced leukopenia and thrombocytopenia after 2 weeks of fusidic acid treatment. In both cases, hematological abnormality resolved in 3 to 6 days after discontinuation of fusidic acid. The published literature regarding hematological adverse effects caused by fusidic acid is reviewed in this report, and an immune-mediated mechanism possibly by drug-dependent antibody is speculated. We recommend periodic complete blood count check in patients receiving long-term fusidic acid treatment to avoid serious hematological adverse effects.
Insights
Fusidic acid can cause rare blood disorders like leukopenia and thrombocytopenia, particularly in Asian populations. Monitoring blood counts during long-term treatment is recommended to prevent adverse effects.
Area of Science:
- Pharmacology
- Hematology
- Infectious Diseases
Background:
- Fusidic acid is effective against Gram-positive bacteria, including MRSA.
- Common side effects include gastrointestinal issues; hematological effects are rare.
- Hematological adverse effects of fusidic acid have not been documented in Asian populations.
Purpose of the Study:
- To report two cases of fusidic acid-induced leukopenia and thrombocytopenia in Asian patients.
- To review the literature on fusidic acid-associated hematological adverse effects.
- To speculate on the mechanism and recommend monitoring.
Main Methods:
- Case report of two patients treated with fusidic acid.
- Review of published literature on fusidic acid's hematological side effects.
- Speculation on immune-mediated mechanisms.
Main Results:
- Two cases of leukopenia and thrombocytopenia occurred after two weeks of fusidic acid treatment.
- Hematological abnormalities resolved within 3-6 days after drug discontinuation.
- Literature review confirmed rare but serious hematological side effects.
Conclusions:
- Fusidic acid can induce leukopenia and thrombocytopenia, even in Asian populations.
- An immune-mediated mechanism involving drug-dependent antibodies is suspected.
- Periodic complete blood count monitoring is advised for patients on long-term fusidic acid therapy.
Related Concept Videos
Disorders of Leukocytes
Leukopenia may result from bone marrow disorders, autoimmune diseases, and infectious diseases. For example, conditions such as multiple myeloma and aplastic anemia can impair the bone marrow's ability to produce adequate leukocytes. Similarly, autoimmune diseases like lupus and viral infections such as HIV can prompt the immune system...
Antiprotozoal Agents
Inhalation Anthrax
Drugs for Treatment of Ulcerative Colitis in IBD
Rocky Mountain Spotted Fever
Cryptococcal Meningitis